MBNL1 and myotonic dystrophy type 1: In this study, we demonstrate that, although susceptible to obstruction by the genetic background, repeat length in DM1 is a major determinant for the degree of aberrant splicing, nuclear MBNL1 levels, and therapeutic effectiveness of ASO strategies.